Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 02 Mar 2023
The COVID-19 pandemic has highlighted the importance of vaccines in controlling the epidemic in sub-Saharan Africa and a renewed interest in vaccine research and development across the country.
Read Full NewsDupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.
Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.
Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.
Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.
Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.
1.
When Should Immunocompromised Individuals Receive a COVID Booster?
2.
Older Adults With Advanced Cancer Prioritize Quality of Life
3.
FDA Approves Next-Gen Agent for Mantle Cell Lymphoma
4.
Can MRI Curb Chemo Overtreatment in Breast Cancer?
5.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
1.
Navigating the Stages of Thyroid Cancer: A Guide for Patients
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Advanced Advances in Oncology for Healthcare Excellence
4.
Polyposis Syndrome: Causes, Symptoms, and Treatment Options
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective
2.
Thromboprophylaxis In Medical Settings
3.
Current Scenario of Cancer- Q&A Session to Close the Gap
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge